中航沈飛(600760.SH):航空工業集團擬向沈飛公司提供20億元財務資助
格隆匯6月8日丨中航沈飛(600760.SH)公佈,為支持公司的生產經營與持續發展,公司控股股東航空工業集團擬向公司全資子公司沈飛公司提供最高總借款額度人民幣20億元整的財務資助,用於補充流動資金,滿足沈飛公司日常生產經營週轉資金需求。最高總借款額度期限為自首次放款之日起算,至最後還款日終止,不超過3年。在此期限內,在不超過最高總借款額度的情況下可多次循環使用;借款利率不高於全國銀行間同業拆借中心公佈的同期貸款市場報價利率,具體以協議為準;公司及全資子公司無需就本次財務資助提供任何抵押或擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.